A prognostic nomogram for patients with resected fibrolamellar hepatocellular carcinoma

机译：纤维状薄层肝细胞癌切除患者的预后列线图

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundFibrolamellar hepatocellular carcinoma (FLHC) is a unique entity compared to conventional hepatocellular carcinoma. The aim of this study was to examine post-resection outcomes and prognostic indicators for survival in this group of FLHC patients.

机译：背景与传统肝细胞癌相比，纤维状肝细胞癌（FLHC）是独特的实体。这项研究的目的是检查这组FLHC患者的切除术后结果和生存预后指标。

著录项

期刊名称 Hepatobiliary Surgery and Nutrition
作者
Kelly J. Lafaro; Oliver S. Eng; Mustafa Raoof; Philip Ituarte; Susanne G. Warner; Gagandeep Singh; Yuman Fong; Laleh G. Melstrom;
展开▼
作者单位

展开▼
年(卷),期 2019(8),4
年度 2019
页码 338–344
总页数 7
原文格式 PDF
正文语种
中图分类营养学;
关键词
入库时间 2022-08-17 12:08:02

相似文献

外文文献
中文文献
专利

1. Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China [J] . Ke Ruisheng, Lv Lizhi, Li Jiayan, Oncology letters . 2018,第3aPta2期

机译：外均核糖核蛋白A1表达和炎症指标对手术切除肝细胞癌患者的预后价值：中国肝细胞癌高疫苗地区的观点
2. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. [J] . Ramacciato G, Mercantini P, Cautero N, Annals of surgical oncology . 2005,第4期

机译：新成立的美国癌症联合委员会/国际抗癌联盟分期系统对肝细胞癌的预后评估：对112例因肝细胞癌切除的肝硬化患者进行分析。
3. Prognostic Evaluation of the New American Joint Committee on Cancer/International Union Against Cancer Staging System for Hepatocellular Carcinoma: Analysis of 112 Cirrhotic Patients Resected for Hepatocellular Carcinoma [J] . Giovanni Ramacciato MD, FACS, Paolo Mercantini MD, Annals of Surgical Oncology . 2005,第4期

机译：新的美国癌症联合委员会/国际抗癌肝癌分期系统联合委员会对肝细胞癌的预后评估：112例肝细胞癌切除的肝硬化患者的分析
4. Matrix Metalloproteinase-2 and High Vascular Endothelial Growth Factor as Prognostic Markers for Intrahepatic Tumor Recurrence in Hepatocellular Carcinoma Patients Receiving Radiotherapy [C] . Eun-Jung Lee, Jinsil Seong, Yang-Gun Suh, Molecular Medicine TRI-CON. . 2014

机译：基质金属蛋白酶-2和高血管内皮生长因子作为肝细胞癌肝癌患者肝内肿瘤复发的预后标志物，接受放射治疗
5. Cyclic AMP Dependent Protein Kinase A (PKA) Mutant Associated with Fibrolamellar Hepatocellular Carcinoma (FLHCC): Structure, Dynamics and in Cell Studies [D] . Karamafrooz, Adak. 2020

机译：与纤维素肝细胞癌（FLHCC）相关的循环AMP依赖性蛋白激酶A（PKA）突变体：结构，动力学和细胞研究
6. Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China [O] . Ruisheng Ke, Lizhi Lv, Jiayan Li, -1

机译：异种核糖核蛋白A1表达和炎性指标对手术切除的肝细胞癌患者的预后价值：从中国肝细胞癌高发地区的观点
7. A prognostic nomogram for patients with resected fibrolamellar hepatocellular carcinoma [O] . Kelly J. Lafaro, Oliver S. Eng, Mustafa Raoof, 2019

机译：患有切除纤维素肝癌肝癌患者的预后载体

A prognostic nomogram for patients with resected fibrolamellar hepatocellular carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅